蛋白酶体抑制剂治疗浆细胞疾病的研究进展(6)
[22] Engelhardt M, Szymaniak-Vits M, Ajayi S, et al. Carfilzomib[J]. Recent Results Cancer Res, 2018, 212: 265-283.[23] Brayer J, Baz R. The potential of ixazomib, a secondgeneration proteasome inhibitor, in the treatment of multiple myeloma [J]. Ther Adv Hematol, 2017, 8(7): 209-220.
[24] Bonnet A ......
您现在查看是摘要页,全文长 2738 字符。